Of note, we found a significant association of higher MFGE8 expression levels with increased measures of cognitive decline in the ROSMAP data (as measured by the Mini Mental State Examination (mmse30) test battery) that was independent of amyloid-β plaque load (CERAD score) and tau pathology (Braak score) (Fig. 2h). The gene discussed is MAPT; the disease is Mental deterioration.